By Donald Zuhn --
StemCellPatents.com has announced the launch of a newly redesigned stem cell patent database. A beta version of the database was launched in November 2006. The stem cell patent database will extend the site's other offerings, which include online news, a weekly e-mail newsletter, the SCP Journal, and a jobs board.
According to a BusinessWire report, the new database contains "comprehensive summaries and analysis of over 1200 patents hand-picked by experts in the field to be of relevance to stem cell commercialization and development." As of Thursday, the stem cell patent database included summaries and bibliographic information for 1,269 U.S. patents relating to stem cells.
Dr. Vladimir Bogin, and member of the site's advisory board and a principle of Cromos Pharma Services, observed that while the media has lately focused its attention on WARF's embryonic stem cell patents, the "minefield of issued patents in the area of stem cell therapy" has been grossly underestimated by the industry. Dr. Bogin noted that by compiling the stem cell patent database, the website hoped to let investigators know "what is out there and what is not, with the hope of accelerating commercialization and, in turn, progress." Other members of the site's advisory board include Don McAdam, the CEO of MBVax Corporation, and Dr. Zhoahui Zhong, a Professor of Medicine at that Hunan Medical University in Changsha, China.
StemCellPatents.com is a great service. Whoever wasted all that time doing all the writing, I hope is getting paid a lot of money :)
Gloria Dolenia
Posted by: Gloria Dolenia | January 04, 2009 at 09:51 PM